← All indications
Venous Thromboembolism
Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
Drugs by status
Approved for this indication (3)
Phase 4 trials (15)
Phase 3 trials (22)
Phase 2 trials (13)
Phase 1 trials (5)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (61)
- Daiichi Sankyo
- Eisai
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- Bayer
- GlaxoSmithKline
- Boehringer Ingelheim
- Danish Heart Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- United States Air Force
- Huazhong University of Science and Technology
- Allegiance Health
- Harvard University
- Duke University
- Gruppo Oncologico Italiano di Ricerca Clinica
- Inonu University
- Johns Hopkins University
- Lebanese American University
- Loyola University
- McMaster University
- Seoul National University
- Spanish Society of Cardiology
- The TIMI Study Group
- University of Miami
- University of Ottawa
- University of Oulu
- University of Tampere
- University of Bern
- University of Bologna
- +31 more
Organization Involved with Phase 3 Indications (73)
- Celgene
- Astellas
- Genentech
- AIO-Studien-gGmbH
- Boston Scientific Corporation
- Cristália Produtos Químicos Farmacêuticos Ltda.
- Rovi Pharmaceuticals Laboratories
- German Research Foundation
- National Cancer Institute (NCI)
- National Cancer Institute, France
- Unity Health Toronto
- Nova Scotia Health Authority
- Air Force Military Medical University, China
- Academic and Community Cancer Research United
- Anhui Medical University
- Cedars-Sinai Medical Center
- Cancer Research Network
- University of London
- Eastern Virginia Medical School
- Indiana University
- McGill University
- Northwell Health
- Qingdao University
- Stanford University
- Universidad Complutense de Madrid
- University of Groningen
- University of Maryland
- University of Padova
- University of Padua
- University of Rochester
- +43 more
Organization Involved with Phase 2 Indications (23)
- Takeda
- Hamilton Health Sciences Corporation
- Ionis Pharmaceuticals, Inc.
- vTv Therapeutics
- University of Washington
- Hanyang University
- New York Medical College
- Ohio State University
- University of Michigan
- University of Southern California
- University of Valencia
- Cardiff University
- University of Colorado, Denver
- University of Ulsan
- University of Gothenburg
- Piacenza Hospital
- University of Colorado
- National Institute for Health Research, United Kingdom
- Trillium Health Partners
- Tetherex Pharmaceuticals Corporation
- Hôpital Montfort
- Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
- Canadian Society of Hematology
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (11)
- Prairie Education and Research Cooperative
- New York University
- Pirogov Russian National Research Medical University
- Nazareth Hospital
- Al Mouwasat Hospital
- Alliance Foundation Trials
- National Taiwan University
- Nazareh Hospital - Mercy Health System
- ARUP Laboratories
- Department of Health and Human Services
- American College of Phlebology